a purified recombinant GST-fusion protein containing N-terminal amino acids 13-316 of PRDM16 of human origin
Modification Notes
The PR-domain containing proteins (PRDMs) have a common involvement in the modulation of gene activities. A PR-domain family member usually produces two products, called PR-plus and PR-minus, which differ by the presence or absence of the PR domain, respectively. The PR-plus product is underexpressed or disrupted in cancer cells, whereas the PR-minus product is present or overexpressed in cancer cells. This imbalance in the amount of the two products, which is a result of either genetic or epigenetic events, appears to be a determining factor of malignancy. PRDM16 (PR domain containing 16), also known as MEL1 or PFM13, is a 1,276 amino acid protein that contains one SET domain and ten C2H2-type zinc fingers. Localized to the nucleus, PRDM16 functions as a transcription factor and is thought to be involved in the pathogenesis of acute myeloid leukemia and myelodysplastic syndrome. Three isoforms of PRDM16 exist due to alternative splicing events.
Key Feature
Clonality
Polyclonal
Isotype
IgG
Host Species
Rabbit
Tested Applications
IFIHCELISA
recommended for detection of PRDM16 of human origin by IF, IHC(P) and ELISA:
Species Reactivity
HumanMouseRat
Concentration
1mg/ml
Purification
Affinity purified
Target Information
Alternative Names
a purified recombinant GST-fusion protein containing N-terminal amino acids 13-316 of PRDM16 of human origin
Tissue Specificity
a purified recombinant GST-fusion protein containing N-terminal amino acids 13-316 of PRDM16 of human origin